Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)
Background: The persisting Coronavirus disease 2019 (COVID-19) pandemic and limited vaccine supply has led to a shift in global health priorities to expand vaccine coverage. Relying on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular testing alone cannot reveal the infection pr...
| Príomhchruthaitheoirí: | , , , , , , , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
MDPI AG
2021-04-01
|
| Sraith: | Vaccines |
| Ábhair: | |
| Rochtain ar líne: | https://www.mdpi.com/2076-393X/9/4/376 |